You are here

Clinical Trials: Eye Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, October 1, 2021 - 12:00
Conditions:   Eye Health;   Age-related Macular Degeneration
Interventions:   Dietary Supplement: Freeze-dried table grape powder;   Dietary Supplement: Placebo of the table grape powder
Sponsors:   National University, Singapore;   National University Hospital, Singapore;   Ministry of Education, Singapore
Not yet recruiting
Posted: Friday, July 23, 2021 - 12:00
Conditions:   CLN3-related Disorders;   Low Vision
Intervention:   Device: OrCam MyEye 2
Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting
Posted: Monday, June 14, 2021 - 12:00
Condition:   Retinitis Pigmentosa
Intervention:   Biological: Intravitreal autologous CD34+ cells
Sponsors:   University of California, Davis;   Cures Within Reach
Recruiting
Posted: Thursday, May 6, 2021 - 12:00
Conditions:   Ciliopathies;   Nephronophthisis;   Senior-Loken Syndrome;   Joubert Syndrome;   Jeune Syndrome;   Bardet-Biedl Syndrome
Interventions:   Other: Blood sample;   Other: Urine sample
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Posted: Friday, February 19, 2021 - 12:00
Condition:   Retinitis Pigmentosa (RP)
Interventions:   Biological: Injection of stem cells in sub-tenon space of eye for the management of retinitis pigmentosa;   Biological: Injection of stem cells in suprachoroidal space of eye for the management of Retinitis Pigmentosa
Sponsors:   Jinnah Burn and Reconstructive Surgery Centre, Lahore;   The Layton Rahmatullah Benevolent Trust (LRBT) Free Eye Hospital, Township Lahore.;   Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore.
Recruiting
Posted: Tuesday, October 27, 2020 - 12:00
Condition:   Retinitis Pigmentosa
Intervention:   Biological: human retinal progenitor cells
Sponsors:   jCyte, Inc;   California Institute for Regenerative Medicine (CIRM)
Not yet recruiting
Posted: Tuesday, October 6, 2020 - 12:00
Condition:   Glaucoma
Interventions:   Drug: NT-501;   Other: Sham comparator
Sponsor:   Stanford University
Not yet recruiting
Posted: Thursday, April 9, 2020 - 12:00
Condition:   Age-Related Macular Degeneration
Intervention:   Combination Product: iPSC-derived RPE/PLGA transplantation
Sponsor:   National Eye Institute (NEI)
Recruiting
Posted: Tuesday, February 25, 2020 - 12:00
Condition:   Retinitis Pigmentosa
Intervention:   Biological: CNS10-NPC implantation
Sponsors:   Cedars-Sinai Medical Center;   California Institute for Regenerative Medicine (CIRM)
Recruiting
Posted: Monday, December 30, 2019 - 12:00
Condition:   Dry Eye
Intervention:   Drug: Umbilical Mesenchymal Stem Cells derived Exosomes
Sponsor:   Zhongshan Ophthalmic Center, Sun Yat-sen University
Not yet recruiting

Pages